5 year old with no symptoms On regular blood work Alt/ ast is in 200 r

5 year old with no symptoms On regular blood work Alt/ ast is in 200 range with cpkmb of 4600

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Searching PubMed

elevated transaminases children muscular dystrophy misdiagnosis liver

I now have all the information needed for a thorough, well-sourced answer. Let me compose it.

Clinical Interpretation: 5-year-old, Asymptomatic, ALT/AST ~200, CK-MB ~4600

The Most Important Point First

This child almost certainly does NOT have primary liver or cardiac disease.

The CK-MB of 4600 U/L is the diagnostic key. At that level (roughly 50-200x normal), this is not a mild cardiac enzyme leak - it points overwhelmingly to skeletal muscle disease, specifically Duchenne Muscular Dystrophy (DMD).

The "liver enzyme" elevation is almost certainly a false alarm: AST and ALT are also released from damaged skeletal muscle, not just the liver. In a child with massive muscle cell breakdown, both transaminases and CK rise together.

"The diagnosis of Duchenne muscular dystrophy should be considered before liver biopsy in any male child with increased transaminases."

Campbell's Operative Orthopaedics, 15th Ed. 2026

Why the Numbers Fit DMD Perfectly

Finding	What It Means
Age 5, male	Classic DMD presentation window (3-5 years)
No symptoms yet	DMD is pre-symptomatic or early-symptomatic at 5; weakness often subtle
CK/CK-MB ~4600	20-200x normal - textbook DMD range; CK is highest BEFORE significant weakness
AST/ALT ~200	Muscle-origin, NOT hepatic; these enzymes are non-specific for liver

From Campbell's Orthopaedics: CK in DMD is elevated 20 to 200 times above normal limits in early disease, and then decreases as muscle mass deteriorates and is replaced by fat and fibrous tissue. So paradoxically, the CK is highest when the child is most "normal-looking."

Also from Robbins Pathologic Basis of Disease: "Boys with Duchenne muscular dystrophy appear normal at birth. Very early motor milestones are met, but walking is often delayed. The first indications of muscle weakness are clumsiness and inability to keep up with peers."

Why "CK-MB" May Be Misleading Here

CK-MB is a CK isoform, and in the context of muscle disease:

In children with myopathy/DMD, total CK is massively elevated and the CK-MB fraction can be disproportionately high, appearing to suggest cardiac origin
A true myocardial infarction in a 5-year-old is exceptionally rare and would present with symptoms
Troponin I is far more cardiac-specific than CK-MB; CK-MB can be elevated by skeletal muscle

Immediate Next Steps

Check sex of child - DMD is X-linked recessive; affects males almost exclusively
Repeat total CK (not just CK-MB) with aldolase - will be massively elevated in DMD
Detailed neuromuscular exam - look for Gower's sign (difficulty rising from floor), calf pseudohypertrophy, subtle proximal weakness
GGT (gamma-glutamyl transferase) - if this is normal while AST/ALT are elevated, it excludes hepatic cholestasis and confirms muscle origin
DNA mutation analysis (PCR or next-generation sequencing) for dystrophin gene (Xp21) - this is diagnostic; can detect >95% of DMD mutations from a blood sample; NO liver biopsy needed
Troponin I - if there is genuine cardiac concern, this is far more specific than CK-MB
Echocardiogram - cardiomyopathy can occur in DMD (typically later), but worth baseline
Refer to pediatric neurology + neuromuscular specialist

Do NOT Do

Do not perform liver biopsy - the textbook explicitly warns against this before ruling out muscular dystrophy
Do not chase hepatic workup (hepatitis panel, liver ultrasound) as the primary pathway without first ruling out myopathy
Do not treat CK-MB elevation as a primary cardiac event

Differential (in decreasing likelihood)

Duchenne Muscular Dystrophy - most likely by far
Becker Muscular Dystrophy - milder, also X-linked, same gene; CK also very high but typically lower than DMD
Other muscular dystrophies / inflammatory myopathy (juvenile dermatomyositis) - less likely without rash or systemic features
Metabolic myopathy (glycogen storage disease type II/Pompe, etc.) - possible, but CK this high favors dystrophin defects
Myocarditis - unlikely without symptoms, fever, or cardiac-specific markers
Viral hepatitis - unlikely to explain CK-MB elevation of 4600; transaminases in viral hepatitis can be high but CK would be normal

Summary

A 5-year-old boy (assuming male) found incidentally to have ALT/AST ~200 and CK-MB ~4600 should be considered to have Duchenne Muscular Dystrophy until proven otherwise. This is a well-described clinical trap: these children are sent for liver workup when the answer is in the muscles. The next step is genetic testing of the dystrophin gene (DMD gene, Xp21). This can be done from blood and is essentially diagnostic.

Campbell's Operative Orthopaedics 15th Ed. 2026, pp. 1719-1720
Robbins Pathologic Basis of Disease (Cotran & Kumar)

Female

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Good - I have the key textbook passage directly addressing girls with this picture. Here is the updated analysis:

Updated Analysis: 5-year-old Female, Asymptomatic, AST/ALT ~200, CK-MB ~4600

Being female narrows the diagnosis but does not eliminate muscle disease - it actually reframes which muscle disease is most likely.

Does This Rule Out DMD?

Mostly, but not completely. From Adams & Victor's Principles of Neurology (12th Ed.):

"Rarely, a severe proximal Duchenne-type muscular dystrophy occurs in young girls. This may have several explanations: the female may have only 1 X chromosome (Turner syndrome, XO) carrying the Duchenne gene, OR the Lyon principle may be operative - inactivation of the unaffected paternal X chromosome allowing expression of the mutated dystrophin in a large proportion of cells (skewed X-inactivation/mosaicism)."

So DMD-in-a-female is rare but real. However, the same textbook says:

"Most childhood dystrophies in girls prove to be of an entirely different type - caused by an autosomal recessive mutation causing a limb-girdle dystrophy."

Revised Differential for a Female with These Numbers

Diagnosis	Likelihood	Key Reasoning
Limb-Girdle Muscular Dystrophy (LGMD) - autosomal recessive	#1 most likely	Most common cause of Duchenne-like picture in girls; CK can be massively elevated; often pre-symptomatic at age 5
Manifesting DMD carrier (skewed X-inactivation)	Possible	Documented phenomenon; girl expresses disease due to Lyon effect or Turner mosaicism
Pompe disease (GSD type II)	Consider	Acid maltase deficiency; can be late-infantile/juvenile onset; CK elevated, often asymptomatic early
Other metabolic myopathies (GSD type III, V)	Consider	Muscle enzyme release without obvious symptoms initially
Juvenile dermatomyositis (JDM)	Lower	Inflammatory; CK elevated but usually presents with rash + weakness; rarely this asymptomatic
Primary liver disease	Very unlikely	Cannot explain CK-MB of 4600

About LGMD in Children

Limb-girdle muscular dystrophies are a group of autosomal recessive (and some dominant) disorders affecting both sexes equally. Key subtypes with early childhood onset and very high CK include:

LGMD R1 (calpainopathy) - most common autosomal recessive type
LGMD R3-R6 (sarcoglycanopathies) - alpha, beta, gamma, delta-sarcoglycan mutations; present in childhood, can mimic DMD exactly, very high CK
LGMD R9 (FKRP-related) - often presents in childhood

These are clinically silent at age 5 while the CK is already sky-high - exactly the pattern here.

Workup for a 5-year-old Girl with This Pattern

First line (blood):

Total CK with fractionation - confirm massively elevated total CK
GGT - if normal, confirms transaminase elevation is muscle-origin, not hepatic
Aldolase - another muscle enzyme, elevated in myopathies
Troponin I (not CK-MB) - if cardiac concern is real; Troponin I is cardiac-specific
LDH - often elevated in muscle disease

Targeted genetics: 6. Next-generation sequencing (NGS) muscular dystrophy gene panel - covers DMD gene (for manifesting carrier), all LGMD subtypes, metabolic myopathies in a single blood test 7. Karyotype - if Turner syndrome (XO) is possible, to explain DMD in a female 8. Acid alpha-glucosidase (GAA) enzyme assay - screens for Pompe disease (dried blood spot test available)

Functional assessment: 9. Detailed neuromuscular exam - Gower's sign, calf pseudohypertrophy, proximal weakness 10. Refer to pediatric neurology/neuromuscular clinic

Cardiac: 11. Echocardiogram - baseline; many muscular dystrophies eventually involve the heart 12. ECG

What NOT to Do

Do not pursue liver biopsy or hepatitis workup as the primary path
Do not dismiss the CK-MB as a lab error at this level
Do not assume it is cardiac without Troponin I confirmation

Bottom Line

A 5-year-old girl with CK ~4600 and mildly elevated transaminases, no symptoms, is a classic presentation of early autosomal recessive Limb-Girdle Muscular Dystrophy, or less commonly a manifesting DMD carrier. The "liver enzymes" are almost certainly coming from muscle, not liver. This child needs a neuromuscular gene panel and pediatric neurology referral urgently - not because she is sick now, but because early diagnosis changes management, genetic counseling, and disease monitoring significantly.

Adams and Victor's Principles of Neurology, 12th Ed., Chapter on Muscular Dystrophies
Campbell's Operative Orthopaedics, 15th Ed. 2026

This is a shared conversation. Sign in to Orris to start your own chat.